In tumor cells, PKM2 predominantly exist in monomeric/dimeric forms due to low levels of allosteric activator fructose bisphosphate (FBS) and due to the presence of phosphorylated PKM2 at Y105 (8) that have an increased binding affinity for pY-containing proteins (9). Here, PKM is linked to neoplasm.